These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2560625)
1. Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene. Pape KA; Floyd-Smith G Anticancer Res; 1989; 9(6):1737-42. PubMed ID: 2560625 [TBL] [Abstract][Full Text] [Related]
2. Modulation of c-myc oncogene expression by phorbol ester and interferon-gamma: appraisal by flow cytometry. Mohamed AN; Nakeff A; Mohammad RM; KuKuruga M; al-Katib A Oncogene; 1988 Oct; 3(4):429-35. PubMed ID: 3152600 [TBL] [Abstract][Full Text] [Related]
3. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents. Futscher BW; Erickson LC Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539 [TBL] [Abstract][Full Text] [Related]
4. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines. Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933 [TBL] [Abstract][Full Text] [Related]
5. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer. Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917 [TBL] [Abstract][Full Text] [Related]
6. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447 [TBL] [Abstract][Full Text] [Related]
7. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030 [TBL] [Abstract][Full Text] [Related]
8. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene. Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395 [TBL] [Abstract][Full Text] [Related]
9. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels. Sharp NA; Luscombe MJ; Clemens MJ Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145 [TBL] [Abstract][Full Text] [Related]
10. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line. Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533 [TBL] [Abstract][Full Text] [Related]
11. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines. Bepler G; Carney DN; Nau MM; Gazdar AF; Minna JD Cancer Res; 1986 Jul; 46(7):3413-9. PubMed ID: 3085922 [TBL] [Abstract][Full Text] [Related]
12. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines. van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061 [TBL] [Abstract][Full Text] [Related]
13. Dissociation of thymidine incorporation and transferrin receptor expression from cell growth and c-myc accumulation in alpha-interferon-treated cells. Meadows LM; George DJ; Kaufman RE J Biol Response Mod; 1990 Apr; 9(2):212-20. PubMed ID: 2187953 [TBL] [Abstract][Full Text] [Related]
14. The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes. Barr LF; Campbell SE; Tamez P; Casero RA Clin Cancer Res; 1998 Jun; 4(6):1557-61. PubMed ID: 9626477 [TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells. Feng R; Shen S; Hui H; Jin M Chin Med J (Engl); 1997 Nov; 110(11):847-50. PubMed ID: 9772416 [TBL] [Abstract][Full Text] [Related]
16. The c-myc protein is constitutively expressed at elevated levels in colorectal carcinoma cell lines. Erisman MD; Scott JK; Watt RA; Astrin SM Oncogene; 1988 Apr; 2(4):367-78. PubMed ID: 3283655 [TBL] [Abstract][Full Text] [Related]
17. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells. St-Arnaud R; Nepveu A; Marcu KB; McBurney MW Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960 [TBL] [Abstract][Full Text] [Related]
18. c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression. Barr LF; Campbell SE; Diette GB; Gabrielson EW; Kim S; Shim H; Dang CV Cancer Res; 2000 Jan; 60(1):143-9. PubMed ID: 10646866 [TBL] [Abstract][Full Text] [Related]
19. Modulation of nuclear proto-oncogene expression and cellular growth in myeloid leukemic cells by human interferon alpha. Marshall AH; Alper D; Hiscott J J Cell Physiol; 1988 May; 135(2):324-31. PubMed ID: 3163696 [TBL] [Abstract][Full Text] [Related]
20. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]